Font Size:
a
A
A
Keyword [Chronic hepatitis c]
Result: 181 - 200 | Page: 10 of 10
181.
Economic Evaluation Of Direct-Acting Antivirals In The Treatment Of Chronic Hepatitis C
182.
The Ultrastructural Characteristics Of The Liver With Mild,Moderate,Severe Hepatitis C And Cancerization
183.
The Study On The Role Of MiR-122 In Lipid Metabolism Disorder Caused By Hepatitis C Virus Infection
184.
Application of the health care system to First Nations and non-First Nations patients with chronic hepatitis C
185.
Autonomic nervous system function in patients with chronic hepatitis C virus infection
186.
The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C
187.
Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection
188.
Assessment of health-related quality of life in adult chronic hepatitis C patients with different categories of disease and sustained response to Intron(rtm) A
189.
Clinical and economic outcomes of direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid
190.
Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States
191.
Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis c genotype 1 infectio
192.
The Efficacy Of Direct-Acting Antiviral Agents In Real World And The Diseases Progression And Clinical Outcomes Of Chronic Hepatitis C With Anti-Viral Treatments
193.
Epidemiological Characteristics Of Patients With Genotype 3 Hepatitis C And Efficacy And Safety Of DAAs
194.
Study On The Effect Of Antiviral Therapy And Antifibrosis Therapy On Lsm Value In Patients With Chronic Hepatitis C
195.
A Long-term Clinical Study Of Virological And Hepatic Benefits Of Patients With Chronic Hepatitis C Virus Infected After DAA Treatment
196.
The Analysis Of Vitamin D Influencing The Outcomes Of Antiviral Therapy And The Prognosis In Patients With Chronic Hepatitis C
197.
Cost-effectiveness Analysis Of Novel Direct-acting Antivirals In The Treatment Of Chronic Hepatitis C In China Based On Markov Model
198.
Hepatitis C Virus In The Epidemic Of Childbearing Age Crowd And Mother-to-child Transmission (PMTCT) Survey: 5 Years Clinical Research Based On The Hospital Data
199.
The Association Between Chronic Hepatitis C And Type 2 Diabetes Mellitus
200.
Investigation On The Efficacy And Safety Of Sofosbuvir,Vipatavir Combined With Ribavirin In The Treatment Of Genotype 3 Chronic Hepatitis C
<<First
<Prev
Next>
Last>>
Jump to